Interest in the combination of antimicrobial therapy for orthopaedic device-related infections due to Enterococcus spp.
Enterococcus faecalis
Outcome
Periprosthetic joint infection
Total hip arthroplasty
Total knee arthroplasty
Journal
Archives of orthopaedic and trauma surgery
ISSN: 1434-3916
Titre abrégé: Arch Orthop Trauma Surg
Pays: Germany
ID NLM: 9011043
Informations de publication
Date de publication:
Sep 2023
Sep 2023
Historique:
received:
29
09
2022
accepted:
14
03
2023
medline:
28
8
2023
pubmed:
30
3
2023
entrez:
29
3
2023
Statut:
ppublish
Résumé
The objective of this study was to evaluate the management of orthopaedic device-related infections (ODRIs) due to Enterococcus spp. We performed a retrospective cohort study in a French tertiary university hospital. Patients with prosthetic joint- or osteosynthesis-associated infections caused by enterococci from 2013 to 2020 were included. Patients who died within 5 days after surgery; who were in palliative care; or who had osteosynthesis of the hand, foot or vertebra were excluded. Thirty-six patients were included, with 24 in the arthroplasty group and 12 in the osteosynthesis material group. Most infections were polymicrobial (63.9%, n = 23). Debridement, antibiotics and implant retention (DAIR) was performed in 30.6% (n = 11), withdrawal of material in 16.7% (n = 6), one-stage exchange in 30.6% (n = 11) and two-stage exchange in 22.2% of cases (n = 8). The antibiotic regimen was amoxicillin in 41.6% (n = 15), rifampicin in 27.8% (n = 10), linezolid in 25% (n = 9) and/or fluoroquinolones in 30.6% (n = 11). Clinical success at 1 year was 67% (18/27). The only variable statistically associated with a decreased risk of clinical failure was a duration of antibiotic therapy of 12 weeks (p = 0.04). Patients with a lower body mass index and age tended to decrease the risk of clinical failure (p = 0.05 and 0.06 respectively). The management of enterococcal ODRIs is complex, and ODRI patients are at high risk for relapse. In our small study, a better outcome was not demonstrated for patients with combination therapy and rifampicin use. Further studies are needed to improve the medico-surgical strategy for treating these infections.
Identifiants
pubmed: 36988713
doi: 10.1007/s00402-023-04848-4
pii: 10.1007/s00402-023-04848-4
doi:
Substances chimiques
Rifampin
VJT6J7R4TR
Anti-Bacterial Agents
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
5515-5526Informations de copyright
© 2023. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.
Références
Pivec R, Johnson AJ, Mears SC, Mont MA (2012) Hip arthroplasty. Lancet 380:1768–1777. https://doi.org/10.1016/s0140-6736(12)60607-2
doi: 10.1016/s0140-6736(12)60607-2
pubmed: 23021846
Zimmerli W, Trampuz A, Ochsner PE (2004) Prosthetic-joint infections. N Engl J Med 351:1645–1654. https://doi.org/10.1056/NEJMra040181
doi: 10.1056/NEJMra040181
pubmed: 15483283
Grammatico-Guillon L, Baron S, Gettner S, Lecuyer AI, Gaborit C, Rosset P, Rusch E, Bernard L (2012) Bone and joint infections in hospitalized patients in France, 2008: clinical and economic outcomes. J Hosp Infect 82:40–48. https://doi.org/10.1016/j.jhin.2012.04.025
doi: 10.1016/j.jhin.2012.04.025
pubmed: 22738613
Cattoir V, Giard JC (2014) Antibiotic resistance in enterococcus faecium clinical isolates. Expert Rev Anti Infect Ther 12:239–248. https://doi.org/10.1586/14787210.2014.870886
doi: 10.1586/14787210.2014.870886
pubmed: 24392717
Bjerke-Kroll BT, Christ AB, McLawhorn AS, Sculco PK, Jules-Elysée KM, Sculco TP (2014) Periprosthetic joint infections treated with two-stage revision over 14 years: an evolving microbiology profile. J Arthroplasty 29:877–882. https://doi.org/10.1016/j.arth.2013.09.053
doi: 10.1016/j.arth.2013.09.053
pubmed: 24199997
Benito N, Franco M, Ribera A, Soriano A, Rodriguez-Pardo D, Sorlí L, Fresco G, Fernández-Sampedro M, Dolores Del Toro M, Guío L, Sánchez-Rivas E, Bahamonde A, Riera M, Esteban J, Baraia-Etxaburu JM, Martínez-Alvarez J, Jover-Sáenz A, Dueñas C, Ramos A, Sobrino B, Euba G, Morata L, Pigrau C, Coll P, Mur I, Ariza J (2016) Time trends in the aetiology of prosthetic joint infections: a multicentre cohort study. Clin Microbiol Infect 22(732):e1-8. https://doi.org/10.1016/j.cmi.2016.05.004
doi: 10.1016/j.cmi.2016.05.004
Segawa H, Tsukayama DT, Kyle RF, Becker DA, Gustilo RB (1999) Infection after total knee arthroplasty. A retrospective study of the treatment of eighty-one infections. J Bone Jt Surg Am. 81:1434–1445. https://doi.org/10.2106/00004623-199910000-00008
doi: 10.2106/00004623-199910000-00008
Marculescu CE, Berbari EF, Hanssen AD, Steckelberg JM, Harmsen SW, Mandrekar JN, Osmon DR (2006) Outcome of prosthetic joint infections treated with debridement and retention of components. Clin Infect Dis 42:471–478. https://doi.org/10.1086/499234
doi: 10.1086/499234
pubmed: 16421790
Tornero E, Senneville E, Euba G, Petersdorf S, Rodriguez-Pardo D, Lakatos B, Ferrari MC, Pilares M, Bahamonde A, Trebse R, Benito N, Sorli L, del Toro MD, Baraiaetxaburu JM, Ramos A, Riera M, Jover-Sáenz A, Palomino J, Ariza J, Soriano A (2014) Characteristics of prosthetic joint infections due to Enterococcus sp. and predictors of failure: a multi-national study. Clin Microbiol Infect 20:1219–1224. https://doi.org/10.1111/1469-0691.12721
doi: 10.1111/1469-0691.12721
pubmed: 24943469
Senthi S, Munro JT, Pitto RP (2011) Infection in total hip replacement: meta-analysis. Int Orthop 35:253–260. https://doi.org/10.1007/s00264-010-1144-z
doi: 10.1007/s00264-010-1144-z
pubmed: 21085957
Rasouli MR, Tripathi MS, Kenyon R, Wetters N, Della Valle CJ, Parvizi J (2012) Low rate of infection control in enterococcal periprosthetic joint infections. Clin Orthop Relat Res 470:2708–2716. https://doi.org/10.1007/s11999-012-2374-8
doi: 10.1007/s11999-012-2374-8
pubmed: 22552769
pmcid: 3442013
Thompson O, Rasmussen M, Stefánsdóttir A, Christensson B, Åkesson P (2019) A population-based study on the treatment and outcome of enterococcal prosthetic joint infections. A consecutive series of 55 cases. J Bone Jt Infect. 4:285–291. https://doi.org/10.7150/jbji.35683
doi: 10.7150/jbji.35683
pubmed: 31966959
pmcid: 6960026
Frank KL, Vergidis P, Brinkman CL, Greenwood Quaintance KE, Barnes AM, Mandrekar JN, Schlievert PM, Dunny GM, Patel R (2015) Evaluation of the Enterococcus faecalis biofilm-associated virulence factors AhrC and eep in rat foreign body osteomyelitis and in vitro biofilm-associated antimicrobial resistance. PLoS ONE 10:e0130187. https://doi.org/10.1371/journal.pone.0130187
doi: 10.1371/journal.pone.0130187
pubmed: 26076451
pmcid: 4467866
Sandoe JA, Wysome J, West AP, Heritage J, Wilcox MH (2006) Measurement of ampicillin, vancomycin, linezolid and gentamicin activity against enterococcal biofilms. J Antimicrob Chemother 57:767–770. https://doi.org/10.1093/jac/dkl013
doi: 10.1093/jac/dkl013
pubmed: 16464896
Société de Pathologie Infectieuse de Langue Française (SPILF); Collège des Universitaires de Maladies Infectieuses et Tropicales (CMIT); Groupe de Pathologie Infectieuse Pédiatrique (GPIP); Société Française d’Anesthésie et de Réanimation (SFAR); Société Française de Chirurgie Orthopédique et Traumatologique (SOFCOT); Société Française d’Hygiène Hospitalière (SFHH); Société Française de Médecine Nucléaire (SFMN); Société Française de Médecine Physique et de Réadaptation (SOFMER); Société Française de Microbiologie (SFM); Société Française de Radiologie (SFR-Rad); Société Française de Rhumatologie (SFR-Rhu) (2010) Recommendations for bone and joint prosthetic device infections in clinical practice (prosthesis, implants, osteosynthesis). Société de pathologie infectieuse de langue Française. Med Mal Infect 40:185–211. https://doi.org/10.1016/j.medmal.2009.12.009
doi: 10.1016/j.medmal.2009.12.009
Ariza J, Cobo J, Baraia-Etxaburu J, Benito N, Bori G, Cabo J, Corona P, Esteban J, Horcajada JP, Lora-Tamayo J, Murillo O, Palomino J, Parra J, Pigrau C, Del Pozo JL, Riera M, Rodríguez D, Sánchez-Somolinos M, Soriano A, Del Toro MD, de la Torre B (2017) Executive summary of management of prosthetic joint infections. Clinical practice guidelines by the Spanish society of infectious diseases and clinical microbiology (SEIMC). Enferm Infecc Microbiol Clin 35:189–195. https://doi.org/10.1016/j.eimc.2016.08.012
doi: 10.1016/j.eimc.2016.08.012
pubmed: 28215487
Osmon DR, Berbari EF, Berendt AR, Lew D, Zimmerli W, Steckelberg JM, Rao N, Hanssen A, Wilson WR (2013) Diagnosis and management of prosthetic joint infection: clinical practice guidelines by the Infectious diseases society of America. Clin Infect Dis 56:e1-25. https://doi.org/10.1093/cid/cis803
doi: 10.1093/cid/cis803
pubmed: 23223583
Amanatullah D, Dennis D, Oltra EG, Marcelino Gomes LS, Goodman SB, Hamlin B, Hansen E, Hashemi-Nejad A, Holst DC, Komnos G, Koutalos A, Malizos K, Martinez Pastor JC, McPherson E, Meermans G, Mooney JA, Mortazavi J, Parsa A, Pécora JR, Pereira GA, Martos MS, Shohat N, Shope AJ, Zullo SS (2019) Hip and knee section, diagnosis, definitions: proceedings of international consensus on orthopedic infections. J Arthroplasty 34:S329–S337. https://doi.org/10.1016/j.arth.2018.09.044
doi: 10.1016/j.arth.2018.09.044
pubmed: 30348576
Tsukayama DT, Goldberg VM, Kyle R (2003) Diagnosis and management of infection after total knee arthroplasty. J Bone Jt Surg Am. 85-A Suppl 1:S75-80. https://doi.org/10.2106/00004623-200300001-00014
doi: 10.2106/00004623-200300001-00014
EUCAST (2020) Clinical breakpoints and dosing of antibiotics. EUCAST
Habib G, Lancellotti P, Antunes MJ, Bongiorni MG, Casalta JP, Del Zotti F, Dulgheru R, El Khoury G, Erba PA, Iung B, Miro JM, Mulder BJ, Plonska-Gosciniak E, Price S, Roos-Hesselink J, Snygg-Martin U, Thuny F, Tornos Mas P, Vilacosta I, Zamorano JL (2015) 2015 ESC guidelines for the management of infective endocarditis: The task force for the management of infective endocarditis of the European society of cardiology (ESC). Endorsed by: European association for cardio-thoracic surgery (EACTS), the European association of nuclear medicine (EANM). Eur Heart J 36:3075–3128. https://doi.org/10.1093/eurheartj/ehv319
doi: 10.1093/eurheartj/ehv319
pubmed: 26320109
Kao PHN, Kline KA (2019) Dr. Jekyll and Mr. Hide: how Enterococcus faecalis subverts the host immune response to cause infection. J Mol Biol 431:2932–2945. https://doi.org/10.1016/j.jmb.2019.05.030
doi: 10.1016/j.jmb.2019.05.030
pubmed: 31132360
El Helou OC, Berbari EF, Marculescu CE, El Atrouni WI, Razonable RR, Steckelberg JM, Hanssen AD, Osmon DR (2008) Outcome of enterococcal prosthetic joint infection: is combination systemic therapy superior to monotherapy? Clin Infect Dis 47:903–909. https://doi.org/10.1086/591536
doi: 10.1086/591536
pubmed: 18754743
Renz N, Trebse R, Akgün D, Perka C, Trampuz A (2019) Enterococcal periprosthetic joint infection: clinical and microbiological findings from an 8-year retrospective cohort study. BMC Infect Dis 19:1083. https://doi.org/10.1186/s12879-019-4691-y
doi: 10.1186/s12879-019-4691-y
pubmed: 31881851
pmcid: 6935141
Kheir MM, Tan TL, Higuera C, George J, Della Valle CJ, Shen M, Parvizi J (2017) Periprosthetic joint infections caused by enterococci have poor outcomes. J Arthroplasty 32:933–947. https://doi.org/10.1016/j.arth.2016.09.017
doi: 10.1016/j.arth.2016.09.017
pubmed: 27789094
Ascione T, Balato G, Mariconda M, Fantoni M, Giovannenze F, Pagliano P (2019) Clinical and prognostic features of prosthetic joint infections caused by Enterococcus spp. Eur Rev Med Pharmacol Sci 23:59–64. https://doi.org/10.26355/eurrev_201904_17475
doi: 10.26355/eurrev_201904_17475
pubmed: 30977872
Ch’ng JH, Chong KKL, Lam LN, Wong JJ, Kline KA (2019) Biofilm-associated infection by enterococci. Nat Rev Microbiol 17(2):82–94. https://doi.org/10.1038/s41579-018-0107-z
doi: 10.1038/s41579-018-0107-z
pubmed: 30337708
Montravers P, Mohler J, Saint Julien L, Carbon C (1997) Evidence of the proinflammatory role of Enterococcus faecalis in polymicrobial peritonitis in rats. Infect Immun 65(1):144–149. https://doi.org/10.1128/iai.65.1.144-149.1997
doi: 10.1128/iai.65.1.144-149.1997
pubmed: 8975904
pmcid: 174568
Tien BYQ, Goh HMS, Chong KKL, Bhaduri-Tagore S, Holec S, Dress R, Ginhoux F, Ingersoll MA, Williams RBH, Kline KA (2017) Enterococcus faecalis promotes innate immune suppression and polymicrobial catheter-associated urinary tract infection. Infect Immun 85:e00378-e417. https://doi.org/10.1128/iai.00378-17
doi: 10.1128/iai.00378-17
pubmed: 28893918
pmcid: 5695114
Ch’ng JH, Muthu M, Chong KKL, Wong JJ, Tan CAZ, Koh ZJS et al (2022) Heme cross-feeding can augment Staphylococcus aureus and Enterococcus faecalis dual species biofilms. ISME J 16(8):2015–2026. https://doi.org/10.1038/s41396-022-01248-1
doi: 10.1038/s41396-022-01248-1
pubmed: 35589966
pmcid: 9296619
Lee K, Lee KM, Kim D, Yoon SS (2017) Molecular determinants of the thickened matrix in a dual-species Pseudomonas aeruginosa and Enterococcus faecalis Biofilm. Appl Environ Microbiol 83(21):e01182-e1217. https://doi.org/10.1128/aem.01182-17
doi: 10.1128/aem.01182-17
pubmed: 28842537
pmcid: 5648906
Weigel LM, Donlan RM, Shin DH, Jensen B, Clark NC, McDougal LK et al (2007) High-level vancomycin-resistant Staphylococcus aureus isolates associated with a polymicrobial biofilm. Antimicrob Agents Chemother 51(1):231–238. https://doi.org/10.1128/aac.00576-06
doi: 10.1128/aac.00576-06
pubmed: 17074796
Duijf SV, Vos FJ, Meis JF, Goosen JH (2015) Debridement, antibiotics and implant retention in early postoperative infection with Enterococcus sp. Clin Microbiol Infect 21:e41–e42. https://doi.org/10.1016/j.cmi.2015.01.006
doi: 10.1016/j.cmi.2015.01.006
pubmed: 25748495
Beganovic M, Luther MK, Rice LB, Arias CA, Rybak MJ, LaPlante KL (2018) A review of combination antimicrobial therapy for Enterococcus faecalis bloodstream infections and infective endocarditis. Clin Infect Dis 67:303–309. https://doi.org/10.1093/cid/ciy064
doi: 10.1093/cid/ciy064
pubmed: 29390132
pmcid: 6248357
Mainardi JL, Gutmann L, Acar JF, Goldstein FW (1995) Synergistic effect of amoxicillin and cefotaxime against Enterococcus faecalis. Antimicrob Agents Chemother 39:1984–1987. https://doi.org/10.1128/aac.39.9.1984
doi: 10.1128/aac.39.9.1984
pubmed: 8540703
pmcid: 162868
Lora-Tamayo J, Murillo O, Iribarren JA, Soriano A, Sánchez-Somolinos M, Baraia-Etxaburu JM, Rico A, Palomino J, Rodríguez-Pardo D, Horcajada JP, Benito N, Bahamonde A, Granados A, del Toro MD, Cobo J, Riera M, Ramos A, Jover-Sáenz A, Ariza J (2013) A large multicenter study of methicillin-susceptible and methicillin-resistant Staphylococcus aureus prosthetic joint infections managed with implant retention. Clin Infect Dis 56:182–194. https://doi.org/10.1093/cid/cis746
doi: 10.1093/cid/cis746
pubmed: 22942204
Senneville E, Joulie D, Legout L, Valette M, Dezèque H, Beltrand E, Roselé B, d’Escrivan T, Loïez C, Caillaux M, Yazdanpanah Y, Maynou C, Migaud H (2011) Outcome and predictors of treatment failure in total hip/knee prosthetic joint infections due to Staphylococcus aureus. Clin Infect Dis 53:33440. https://doi.org/10.1093/cid/cir402
doi: 10.1093/cid/cir402
Hoogkamp-Korstanje JA (1997) In-vitro activities of ciprofloxacin, levofloxacin, lomefloxacin, ofloxacin, pefloxacin, sparfloxacin and trovafloxacin against gram-positive and gram-negative pathogens from respiratory tract infections. J Antimicrob Chemother 40:427–431. https://doi.org/10.1093/jac/40.3.427
doi: 10.1093/jac/40.3.427
pubmed: 9338498
Radcliffe GS, Tomichan MC, Andrews M, Stone MH (1999) Revision hip surgery in the elderly: is it worthwhile? J Arthroplasty 14(1):38–44. https://doi.org/10.1016/s0883-5403(99)90200-0
doi: 10.1016/s0883-5403(99)90200-0
pubmed: 9926951
Jamakorzyan C, Meyssonnier V, Kerroumi Y, Villain B, Heym B, Lhotellier L et al (2019) Curative treatment of prosthetic joint infection in patients younger than 80 vs. 80 or older. Jt Bone Spine. 86(3):369–372. https://doi.org/10.1016/j.jbspin.2019.01.017
doi: 10.1016/j.jbspin.2019.01.017
Aw D, Silva AB, Palmer DB (2007) Immunosenescence: emerging challenges for an ageing population. Immunology 120(4):435–446. https://doi.org/10.1111/j.1365-2567.2007.02555.x
doi: 10.1111/j.1365-2567.2007.02555.x
pubmed: 17313487
pmcid: 2265901
Walter N, Rupp M, Bärtl S, Uecker C, Alt V (2022) The definition of the term ‘Orthogeriatric Infection’ for periprosthetic joint infections. Geriatr Orthop Surg Rehabil 13:21514593221111650. https://doi.org/10.1177/21514593221111649
doi: 10.1177/21514593221111649
Bernard L, Arvieux C, Brunschweiler B, Touchais S, Ansart S, Bru JP, Oziol E, Boeri C, Gras G, Druon J, Rosset P, Senneville E, Bentayeb H, Bouhour D, Le Moal G, Michon J, Aumaître H, Forestier E, Laffosse JM, Begué T, Chirouze C, Dauchy FA, Devaud E, Martha B, Burgot D, Boutoille D, Stindel E, Dinh A, Bemer P, Giraudeau B, Issartel B, Caille A (2021) Antibiotic therapy for 6 or 12 weeks for prosthetic joint infection. N Engl J Med 384:1991–2001. https://doi.org/10.1056/NEJMoa2020
doi: 10.1056/NEJMoa2020
pubmed: 34042388